#beijing-china, #brazil, #china, #china-national-pharmaceutical-group-corp-sinopharm, #drugs-pharmaceuticals, #internal-essential, #moderna-inc, #pfizer-inc, #research, #rna-ribonucleic-acid, #vaccination-and-immunization
Collaborating with devoted colleagues, Dr. Kariko laid the groundwork for the mRNA vaccines turning the tide of the pandemic.
An oily, 100-nanometer-wide bubble of genes has killed more than two million people and reshaped the world. Scientists don’t quite know what to make of it.
Politics is grim but science is working.
New studies underscore how coronaviruses frequently mix their genetic components — which could contribute to the rise of dangerous variants.
Scientists are exploring the physics of viruses, to understand how these pathogens assemble themselves — and might be rent apart.
The first shots could be given as early as Dec. 21, if authorization is granted.
The company said it planned to apply for emergency approval from the Food and Drug Administration “within days.”
Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.
New research found ‘autoantibodies’ similar to those in lupus and rheumatoid arthritis patients. But patients may also benefit from treatments for those autoimmune diseases.
President Trump’s recent tests are a reminder that although many products exist, none test for infectiousness.
George Washington University Hospital invited me to participate in Moderna’s vaccine trial because I am triple-risk: a Black woman, a Type 1 diabetic and asthmatic.
SARS-CoV-2 has been slowly changing in small ways, without getting more dangerous.
Airborne virus plays a significant role in community transmission, many experts believe. A new study fills in the missing piece: Floating virus can infect cells.
A novel gene-editing experiment seems to have permanently reduced LDL and triglyceride levels in monkeys.
The French drugmaker is testing two types of vaccines in a bid to catch up to competitors.
Our “hidden enemy,” in plain sight.
The drug failed as a treatment for hepatitis and Ebola. With federal funding, scientists trained it on the coronavirus.
There aren’t enough. Many are shoddy. Most aren’t even designed to tell us what we really want to know.
Scientists traced the virus brought to the Seattle area in January. They were astonished to learn that the same branch of the virus traveled on through at least a dozen states and to other parts of the world.